Skip to main content
European Commission logo
Deutsch Deutsch
CORDIS - Forschungsergebnisse der EU
CORDIS

ERA-NET ON NANOMEDICINE

Ziel

Nanomedicine is the application of nanotechnology to medicine and healthcare. The field takes advantage of the physical, chemical and biological properties of materials at the nanometer scale to be used for a better understanding of the biological mechanisms of diseases at the molecular level, leading to new targets for earlier and more precise diagnostics and therapeutics. Nanomedicine, rated among the six most promising Key Enabling Technologies, is one of the most important emerging areas of health research expected to contribute to one of the strategic challenges that Europe has to face in the future: Provide effective and affordable health care and assure the wellbeing of an increasingly aged population.

EuroNanoMed III (ENM III) builds on the foundations of ENM I & II, which launched 7 successful joint calls for proposals since 2009, funded 51 transnational research projects involving 269 partners from 25 countries/regions, and allocated € 45,5 million to research projects from ENM funding agencies. ENM III consortium, reinforced with 12 new partners from Europe, Canada and Taiwan, is committed to fostering the competiveness of European nanomedicine actors taking into account recent changes in the landscape and new stakeholders and challenges, as identified in the SRIA in nanomedicine. The first joint call for proposals will be co-funded by ENM III partners and the EC. After the co-funded call, three additional joint transnational calls will be organized and strategic activities will be accomplished in collaboration with key initiatives in the field. ENM III actions focus on translatability of project results to clinical and industry needs.

Schlüsselbegriffe

Programm/Programme

Thema/Themen

Aufforderung zur Vorschlagseinreichung

H2020-NMBP-2016-2017

Andere Projekte für diesen Aufruf anzeigen

Unterauftrag

H2020-NMBP-ERA-NET-2016

Finanzierungsplan

ERA-NET-Cofund - ERA-NET Cofund

Koordinator

INSTITUTO DE SALUD CARLOS III
Netto-EU-Beitrag
€ 212 850,00
Adresse
MONFORTE DE LEMOS 5
28029 Madrid
Spanien

Auf der Karte ansehen
Region
Comunidad de Madrid Comunidad de Madrid Madrid
Aktivitätstyp
Research Organisations
Links
Gesamtkosten
€ 645 000,00

Beteiligte (28)

Diese Seite teilen

Herunterladen

Letzte Aktualisierung: 15 Juli 2024

Mein Booklet

Permalink: https://cordis.europa.eu/project/id/723770/de

European Union, 2024